Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Benjamin

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Transfusion|August 2, 2020
Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reductionJoy L Fridey, Susan L Stramer, Ashok Nambiar, et al.
Transfusion|March 29, 2019
Transfusion of pathogen-reduced platelet components without leukoreductionJoycelyn Sim, Wai Chiu Tsoi, Cheuk Kwong Lee, et al.
Haematologica|January 19, 2007
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working GroupTapani Ruutu, Giovanni Barosi, Richard J Benjamin, et al.
Transfusion|July 18, 2008
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006Anne F Eder, Beth A Dy, Jean M Kennedy, et al.
Transfusion|December 25, 2024
Characterizing the antibody response to amustaline/glutathione pathogen-reduced red blood cellsChristopher Karim, Anil Panigrahi, Ronald G Pearl, et al.
Transfusion|July 9, 2022
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storageJose A Cancelas, Jamie R Genthe, Moritz Stolla, et al.
Transfusion|May 31, 2019
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)Chintamani Atreya, Simone Glynn, Michael Busch, et al.
Transfusion|March 3, 2018
Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgeryVeronika Brixner, Arndt-Holger Kiessling, Katharina Madlener, et al.
Transfusion|September 28, 2006
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraPaul D Mintz, Anne Neff, Malcolm MacKenzie, et al.
Anesthesiology|October 14, 2025
Transfusion of Amustaline/Glutathione Pathogen-reduced Red Blood Cells in Cardiac Surgery: A Randomized Phase 3 Clinical TrialMichael E Sekela, Edward L Snyder, Ian J Welsby, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Transfusion|August 2, 2020
Sepsis from an apheresis platelet contaminated with Acinetobacter calcoaceticus/baumannii complex bacteria and Staphylococcus saprophyticus after pathogen reductionJoy L Fridey, Susan L Stramer, Ashok Nambiar, et al.
Transfusion|March 29, 2019
Transfusion of pathogen-reduced platelet components without leukoreductionJoycelyn Sim, Wai Chiu Tsoi, Cheuk Kwong Lee, et al.
Haematologica|January 19, 2007
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working GroupTapani Ruutu, Giovanni Barosi, Richard J Benjamin, et al.
Transfusion|July 18, 2008
The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006Anne F Eder, Beth A Dy, Jean M Kennedy, et al.
Transfusion|December 25, 2024
Characterizing the antibody response to amustaline/glutathione pathogen-reduced red blood cellsChristopher Karim, Anil Panigrahi, Ronald G Pearl, et al.
Transfusion|July 9, 2022
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storageJose A Cancelas, Jamie R Genthe, Moritz Stolla, et al.
Transfusion|May 31, 2019
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026)Chintamani Atreya, Simone Glynn, Michael Busch, et al.
Transfusion|March 3, 2018
Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgeryVeronika Brixner, Arndt-Holger Kiessling, Katharina Madlener, et al.
Transfusion|September 28, 2006
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpuraPaul D Mintz, Anne Neff, Malcolm MacKenzie, et al.
Anesthesiology|October 14, 2025
Transfusion of Amustaline/Glutathione Pathogen-reduced Red Blood Cells in Cardiac Surgery: A Randomized Phase 3 Clinical TrialMichael E Sekela, Edward L Snyder, Ian J Welsby, et al.
Pageof 9